Evidence map›Paper›PMID 33980897›Full record

ArticleScientific reports2021

Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health.

Sarah J D Nauwelaerts, Nancy H C Roosens, Alfred Bernard, Sigrid C J De Keersmaecker, Koen De Cremer

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sarah J D NauwelaertsTransversal Activities in Applied Genomics, Sciensano, Brussels, Belgium.
Nancy H C RoosensTransversal Activities in Applied Genomics, Sciensano, Brussels, Belgium.
Alfred BernardLouvain Centre for Toxicology and Applied Pharmacology, University catholique de Louvain, Woluwe, Brussels, Belgium.
Sigrid C J De KeersmaeckerTransversal Activities in Applied Genomics, Sciensano, Brussels, Belgium.
Koen De CremerPlatform Chromatography and Mass Spectrometry, Sciensano, Brussels, Belgium. koen.decremer@sciensano.be.
Sciensano (Belgium) · BEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory health of children is a health priority. Club cell protein (CC16) is an interesting biomarker of lung diseases and adverse effects towards the airway epithelium integrity. Osteopontin (OPN) and nuclear factor-kappa B (NF-κB) also play a role in respiratory health. The use of urine as biomarker source is useful in studies involving children but necessitates proper adjustment for physiological confounders influencing the urinary excretion, potentially characterized with beta-2-microglobulin (β2M), retinol binding protein 4 (RBP4) or myoglobin (MYO), as well as adjustment for possible renal dysfunction, characterized by human serum albumin (HSA). The simultaneous quantification of all these proteins in urine could facilitate children's health monitoring. A multiple reaction monitoring method (MRM) was developed and validated for the relative quantification of the seven mentioned urinary proteins. A total of nine proteotypic peptides were selected and used for the relative quantification of the seven proteins. The MRM method was completely validated for all proteins and partially for OPN. LOQ's ranged from 0.3 to 42.8 ng/ml, a good reproducibility and a good linearity were obtained across the analytical measurement range (r

Indexed as

beta 2-MicroglobulinBiomarkersChildChild, PreschoolChromatography, High Pressure LiquidFemaleHumansMaleOsteopontinProspective StudiesRespiratory Tract DiseasesRetinol-Binding Proteins, PlasmaTandem Mass SpectrometryUrineB2M protein, humanbeta 2-MicroglobulinBiomarkersOsteopontinRBP4 protein, humanRetinol-Binding Proteins, Plasma

Identifiers

PMID33980897
PMCPMC8115669
OpenAlexW3163438921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.